Deal reached on US track-and-trace, drug compounding bill
This article was originally published in SRA
Executive Summary
A bicameral, bipartisan group of US lawmakers have hammered out a compromise bill that would put in place a uniform national policy for tracking and tracing drugs from manufacture to distribution with the aim of preventing counterfeits products from entering the supply chain1,2.